Author:
Rauchenwald Michael,De Santis Maria,Fink Eleonore,Höltl Wolfgang,Kramer Gero,Marei Isabella-Carolina,Neumann Hans-Jörg,Reissigl Andreas,Schmeller Nikolaus,Stackl Walter,Hobisch Alfred,Krainer Michael
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Keine Autoren angegeben: SEER Stage Distribution by Race For Prostate Cancer, All Ages, Males, SEER 9 Registries for 1975–1979, 1985–1989, 1996–2003. SEER – Surveillance Epidemiology and End Results
2. Vutuc C, Waldhoer T, Madersbacher S, Micksche M, Haidinger G (2001) Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality. Eur J Cancer Prev 10(5): 425–428
3. Statistik Austria: Prostata. Gesundheitsstatistiken/Inzidenz von Krebserkrankungen 2001–2003. www.statistik.at/web_de/statistiken/gesundheit/krebserkrankungen/prostata/index.html . Zuletzt aufgerufen am 26.10.2007
4. Chang SS, Benson MC, Campbell SC, Crook J, Dreicer R, Evans CP, et al (2005) Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma. Cancer 103(1): 11–21
5. Scher HI, Steineck G, Kelly WK (1995) Hormone-refractory (D3) prostate cancer: refining the concept. Urology 46(2): 142–148
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献